8 hours ago
With agents like semaglutide and tirzepatide becoming household drug names, Peterson discusses the short-term future of incretin drug development.
8 hours ago
The matters of long-term PCOS management may heavily depend on what stage of life the patient is in—and how the disease itself has presented.
11 hours ago
Wei Ling Lau, MD, explains the importance of medication adherence to maximize the benefits of RAASi therapy.
12 hours ago
Wei Ling Lau, MD, explains how to enable optimal RAASi therapy while reducing hyperkalemia risk.
13 hours ago
Michael Shlipak, MD, MPH, explains updates to the American Heart Association's cardiovascular risk equation, which now incorporates kidney function and damage through albuminuria into its components.